BVD2-23B6 constitutes the innovative therapeutic tool intended to specifically neutralize human GM-CSF. Developed by sophisticated antibody creation techniques, this agent demonstrates significant binding and https://www.targetmol.com/compound/anti-human-gm-csf-antibody-bvd2-23b6